PharmaShots | Incisive News in 3 Shots

Subscribe Now

Apollomics

Apollomics Reports First Patient Dosing in P-III Clinical Trial of Uproleselan for the Treatment of AML

Apollomics Reports First Patient Dosing in P-III Clinical Trial of Uproleselan for the Treatment of AML

November 24, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us